224 related articles for article (PubMed ID: 31512207)
1. Targeted Mutations in the Mouse via Embryonic Stem Cells.
Gertsenstein M; Mianné J; Teboul L; Nutter LMJ
Methods Mol Biol; 2020; 2066():59-82. PubMed ID: 31512207
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-Mediated Insertion of loxP Sites in the Mouse Dock7 Gene Provides an Effective Alternative to Use of Targeted Embryonic Stem Cells.
Bishop KA; Harrington A; Kouranova E; Weinstein EJ; Rosen CJ; Cui X; Liaw L
G3 (Bethesda); 2016 Jul; 6(7):2051-61. PubMed ID: 27175020
[TBL] [Abstract][Full Text] [Related]
3. TALEN- and CRISPR-enhanced DNA homologous recombination for gene editing in zebrafish.
Zhang Y; Huang H; Zhang B; Lin S
Methods Cell Biol; 2016; 135():107-20. PubMed ID: 27443922
[TBL] [Abstract][Full Text] [Related]
4. Use of two gRNAs for CRISPR/Cas9 improves bi-allelic homologous recombination efficiency in mouse embryonic stem cells.
Acosta S; Fiore L; Carota IA; Oliver G
Genesis; 2018 May; 56(5):e23212. PubMed ID: 29676032
[TBL] [Abstract][Full Text] [Related]
5. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System.
Xue H; Wu J; Li S; Rao MS; Liu Y
Methods Mol Biol; 2016; 1307():173-90. PubMed ID: 24615461
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
7. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
8. Targeted plant genome editing via the CRISPR/Cas9 technology.
Li JF; Zhang D; Sheen J
Methods Mol Biol; 2015; 1284():239-55. PubMed ID: 25757776
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
Kim HM; Colaiácovo MP
Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
[TBL] [Abstract][Full Text] [Related]
10. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
[TBL] [Abstract][Full Text] [Related]
11. Genome-scale CRISPR pooled screens.
Sanjana NE
Anal Biochem; 2017 Sep; 532():95-99. PubMed ID: 27261176
[TBL] [Abstract][Full Text] [Related]
12. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
13. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
15. Gene Editing of Mouse Embryonic and Epiblast Stem Cells.
Sibbritt T; Osteil P; Fan X; Sun J; Salehin N; Knowles H; Shen J; Tam PPL
Methods Mol Biol; 2019; 1940():77-95. PubMed ID: 30788819
[TBL] [Abstract][Full Text] [Related]
16. Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells.
Sun JJ; Ray R
PLoS One; 2016; 11(7):e0159474. PubMed ID: 27441631
[TBL] [Abstract][Full Text] [Related]
17. Conditional Control of CRISPR/Cas9 Function.
Zhou W; Deiters A
Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
[TBL] [Abstract][Full Text] [Related]
18. Creation of zebrafish knock-in reporter lines in the nefma gene by Cas9-mediated homologous recombination.
Eschstruth A; Schneider-Maunoury S; Giudicelli F
Genesis; 2020 Jan; 58(1):e23340. PubMed ID: 31571409
[TBL] [Abstract][Full Text] [Related]
19. P53 ICE CRIM mouse: a tool to generate mutant allelic series in somatic cells and germ lines for cancer studies.
Fan HH; Yu IS; Lin YH; Wang SY; Liaw YH; Chen PL; Yang TL; Lin SW; Chen YT
FASEB J; 2019 Apr; 33(4):5571-5584. PubMed ID: 30640520
[TBL] [Abstract][Full Text] [Related]
20. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
